Sam Egger
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Sam Egger has a total of 159 co-authors. Here are the top co-authors by number of shared publications:
Becky Freeman
6 shared publications- David Paul Smith
The Daffodil Centre, The University of Sydney, a joint venture with Cancer Council NSW, Sydney, New South Wales, Australia; School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia
6 shared publications - Qingwei Luo
The Daffodil Centre, The University of Sydney, a joint venture with Cancer Council NSW, Sydney, New South Wales, Australia
6 shared publications - Becky Freeman
School of Public Health, Faculty of Medicine and Health, The University of Sydney, Sydney, Australia
5 shared publications - Freddy Sitas
UNSW
4 shared publications Judith McCool
4 shared publications
Latest Publications
- 15 October 2026
- Published by Elsevier in The Lancet
- Vol. 408 (10564) , 1551
Smoking rates: when should harm-reduction evidence be updated?
- 15 October 2026
- Published by Elsevier in The Lancet
- Vol. 408 (10564) , 1551
Smoking rates: when should harm-reduction evidence be updated?
- Open Access
- 21 August 2026
- Published by Elsevier in The Lancet Regional Health - Western Pacific
- Vol. 75
New Zealand's smoking decline and plateau: cautionary lessons for tobacco harm reduction
- 21 August 2026
- Published by Elsevier in The Lancet Regional Health - Western Pacific
- Vol. 75
Open AccessNew Zealand's smoking decline and plateau: cautionary lessons for tobacco harm reduction
- Open Access
Problems in comparing tobacco regulatory models and excise when only two countries are considered
- Open Access
- 5 November 2025
- Published by Elsevier in The Lancet Regional Health - Western Pacific
- Vol. 64
Trends in smoking prevalence before and after the emergence of vaping in Aotearoa/New Zealand among 14–15-year-olds identifying as Māori, Pacific, European, or Asian: an interrupted time series analysis of repeated cross-sectional data, 2003–2024
- 5 November 2025
- Published by Elsevier in The Lancet Regional Health - Western Pacific
- Vol. 64
Open AccessTrends in smoking prevalence before and after the emergence of vaping in Aotearoa/New Zealand among 14–15-year-olds identifying as Māori, Pacific, European, or Asian: an interrupted time series analysis of repeated cross-sectional data, 2003–2024
- Open Access
- 4 September 2025
- Published by BMJ in BMJ Public Health
- Vol. 3 (2) , e002414
Vaping health perceptions and never vaping among Australian adolescents: a strength-based analysis of cross-sectional survey data
Introduction: Curbing adolescent vaping is a public health priority and little evidence exists examining protective factors. Using a strength-based approach, this study explored the relationship between adolescent vaping health perceptions and vaping use. Methods: Cross-sectional data from 9000 Australian adolescents aged 14–17 years recruited via multiple online panels as part of the Generation Vape Study were used. Logistic regression compared never vs ever vaping, and inversed multinomial logistic regression compared never vaping to four lifetime vaping categories (ranging from use on a few to >100 occasions) for eight health perceptions. Results: Overall, 66% (5948/9000) of participants reported never vaping. Within all vaping categories, most agreed that vapes are unsafe, can harm the lungs and brain and can cause addiction, and disagreed that nicotine is harmless. Compared with those who disagreed/strongly disagreed, the odds of never vs ever vaping were greater among those who agreed/strongly agreed that vapes are unsafe to use (adjusted OR=2.67; 95% CI 2.17 to 3.27), can harm the developing brain (2.61; 2.05 to 3.33), can damage the lungs (1.61; 1.23 to 2.10), can cause addiction (2.32; 1.79 to 3.00) and that they are unsafe to use around others (2.94; 2.48 to 3.49). Compared with those who agreed/strongly agreed that nicotine is harmless, there were greater odds of never use (vs ever use) among those who disagreed/strongly disagreed (1.75; 1.44 to 2.11). The protective relationship remained across different lifetime vaping categories. Neither agreeing nor disagreeing was not generally a factor protective against vaping. Conclusion: Perceptions of vape harms appear protective against experimental and regular vaping. Young people vape despite the majority of users being aware of harms, suggesting knowledge alone is an unlikely driver of behaviour. Comprehensive control efforts that embrace a suite of actions including education, policy, enforcement and monitoring activities are needed to best protect adolescent health.
- 4 September 2025
- Published by BMJ in BMJ Public Health
- Vol. 3 (2) , e002414
Open AccessVaping health perceptions and never vaping among Australian adolescents: a strength-based analysis of cross-sectional survey data
Introduction: Curbing adolescent vaping is a public health priority and little evidence exists examining protective factors. Using a strength-based approach, this study explored the relationship between adolescent vaping health perceptions and vaping use. Methods: Cross-sectional data from 9000 Australian adolescents aged 14–17 years recruited via multiple online panels as part of the Generation Vape Study were used. Logistic regression compared never vs ever vaping, and inversed multinomial logistic regression compared never vaping to four lifetime vaping categories (ranging from use on a few to >100 occasions) for eight health perceptions. Results: Overall, 66% (5948/9000) of participants reported never vaping. Within all vaping categories, most agreed that vapes are unsafe, can harm the lungs and brain and can cause addiction, and disagreed that nicotine is harmless. Compared with those who disagreed/strongly disagreed, the odds of never vs ever vaping were greater among those who agreed/strongly agreed that vapes are unsafe to use (adjusted OR=2.67; 95% CI 2.17 to 3.27), can harm the developing brain (2.61; 2.05 to 3.33), can damage the lungs (1.61; 1.23 to 2.10), can cause addiction (2.32; 1.79 to 3.00) and that they are unsafe to use around others (2.94; 2.48 to 3.49). Compared with those who agreed/strongly agreed that nicotine is harmless, there were greater odds of never use (vs ever use) among those who disagreed/strongly disagreed (1.75; 1.44 to 2.11). The protective relationship remained across different lifetime vaping categories. Neither agreeing nor disagreeing was not generally a factor protective against vaping. Conclusion: Perceptions of vape harms appear protective against experimental and regular vaping. Young people vape despite the majority of users being aware of harms, suggesting knowledge alone is an unlikely driver of behaviour. Comprehensive control efforts that embrace a suite of actions including education, policy, enforcement and monitoring activities are needed to best protect adolescent health.
- Open Access
- 8 August 2025
- Published by Elsevier in The Lancet Regional Health - Western Pacific
- Vol. 61, 101657
Caution is always needed when interpreting population-level vaping and smoking trends–authors' reply
- 8 August 2025
- Published by Elsevier in The Lancet Regional Health - Western Pacific
- Vol. 61, 101657
Open AccessCaution is always needed when interpreting population-level vaping and smoking trends–authors' reply
- Open Access
- 27 July 2025
- Published by Wiley in Medical Journal of Australia
- Vol. 223 (10) , 517-524
Trends in adolescent smoking prevalence before and after the emergence of vaping in Australia: an interrupted time series analysis, 1999–2023
Objective: To compare adolescent smoking trends in Australia before and after the emergence of e‐cigarettes in about 2010, to evaluate the potential impacts of adolescent vaping on smoking prevalence. Design: Repeated cross‐sectional study. Setting: Australian secondary schools. Participants: 172 406 students aged 12–17 years who took part in the Australian Secondary Students’ Alcohol and Drug Survey between 1999 and 2023. Main outcome measures: Prevalence of ever, past year, past month and past week smoking for 12–17‐year‐olds, and daily smoking for 14–15‐year‐olds. Results: From 2014 to 2022–2023, the prevalence of ever vaping among students increased 2.3‐fold (from 13.2% to 29.9%), while past month vaping increased 4.8‐fold (from 3.3% to 15.7%). From 1999 to 2022–2023, there were substantial declines in the prevalence of ever, past year, past month, past week and daily smoking among students, with reductions ranging between 74% and 89%. However, the rates of decline for these five measures of smoking slowed significantly from 2010 onwards, coinciding with the emergence of vaping. By 2022–2023, there were, respectively, 74 (95% confidence interval [CI], 67–80), 54 (95% CI, 48–60), 25 (95% CI, 21–29) and 16 (95% CI, 12–19) more 12–17‐year‐olds per 1000, and 7 (95% CI, 4–9) more 14–15‐year‐olds per 1000 who had engaged in ever, past year, past month, past week and daily smoking than projected by smoking trajectories from the pre‐vaping era. These findings were robust to sensitivity analyses, including the use of different time series interruption points (change‐years) and controlling for the affordability of cigarettes. Conclusion: Australia’s remarkable progress in reducing adolescent smoking has slowed since the emergence of vaping, underscoring the need for integrated tobacco and vaping control strategies.
- 27 July 2025
- Published by Wiley in Medical Journal of Australia
- Vol. 223 (10) , 517-524
Open AccessTrends in adolescent smoking prevalence before and after the emergence of vaping in Australia: an interrupted time series analysis, 1999–2023
Objective: To compare adolescent smoking trends in Australia before and after the emergence of e‐cigarettes in about 2010, to evaluate the potential impacts of adolescent vaping on smoking prevalence. Design: Repeated cross‐sectional study. Setting: Australian secondary schools. Participants: 172 406 students aged 12–17 years who took part in the Australian Secondary Students’ Alcohol and Drug Survey between 1999 and 2023. Main outcome measures: Prevalence of ever, past year, past month and past week smoking for 12–17‐year‐olds, and daily smoking for 14–15‐year‐olds. Results: From 2014 to 2022–2023, the prevalence of ever vaping among students increased 2.3‐fold (from 13.2% to 29.9%), while past month vaping increased 4.8‐fold (from 3.3% to 15.7%). From 1999 to 2022–2023, there were substantial declines in the prevalence of ever, past year, past month, past week and daily smoking among students, with reductions ranging between 74% and 89%. However, the rates of decline for these five measures of smoking slowed significantly from 2010 onwards, coinciding with the emergence of vaping. By 2022–2023, there were, respectively, 74 (95% confidence interval [CI], 67–80), 54 (95% CI, 48–60), 25 (95% CI, 21–29) and 16 (95% CI, 12–19) more 12–17‐year‐olds per 1000, and 7 (95% CI, 4–9) more 14–15‐year‐olds per 1000 who had engaged in ever, past year, past month, past week and daily smoking than projected by smoking trajectories from the pre‐vaping era. These findings were robust to sensitivity analyses, including the use of different time series interruption points (change‐years) and controlling for the affordability of cigarettes. Conclusion: Australia’s remarkable progress in reducing adolescent smoking has slowed since the emergence of vaping, underscoring the need for integrated tobacco and vaping control strategies.
- Open Access
- 21 March 2025
- Published by Elsevier in The Lancet Regional Health - Western Pacific
- Vol. 56, 101522
Trends in smoking prevalence among 14–15-year-old adolescents before and after the emergence of vaping in New Zealand; an interrupted time series analysis of repeated cross-sectional data, 1999–2023
- 21 March 2025
- Published by Elsevier in The Lancet Regional Health - Western Pacific
- Vol. 56, 101522
Open AccessTrends in smoking prevalence among 14–15-year-old adolescents before and after the emergence of vaping in New Zealand; an interrupted time series analysis of repeated cross-sectional data, 1999–2023
- Open Access
- 17 March 2025
- Published by CSIRO Publishing in Public Health Research & Practice
- Vol. 35 (1)
Misread signals: a misinterpretation of population-level vaping and smoking trends
The increasing prevalence of e-cigarette use (vaping) among adolescents and young adults has ignited debate over its potential role in the initiation of cigarette smoking. Prospective cohort studies at the individual level consistently demonstrate a higher risk of smoking initiation among young people who have previously vaped when compared with those who have never vaped (sometimes called a ‘gateway effect’). On the other hand, several studies analysing repeated cross-sectional data argue that vaping might decrease the risk of smoking through a ‘displacement effect’, as evidenced by an increasing vaping trend coinciding with a decreasing smoking trend. This perspective article examines these conflicting viewpoints in the context of a misinterpretation of these coinciding trends.
- 17 March 2025
- Published by CSIRO Publishing in Public Health Research & Practice
- Vol. 35 (1)
Open AccessMisread signals: a misinterpretation of population-level vaping and smoking trends
The increasing prevalence of e-cigarette use (vaping) among adolescents and young adults has ignited debate over its potential role in the initiation of cigarette smoking. Prospective cohort studies at the individual level consistently demonstrate a higher risk of smoking initiation among young people who have previously vaped when compared with those who have never vaped (sometimes called a ‘gateway effect’). On the other hand, several studies analysing repeated cross-sectional data argue that vaping might decrease the risk of smoking through a ‘displacement effect’, as evidenced by an increasing vaping trend coinciding with a decreasing smoking trend. This perspective article examines these conflicting viewpoints in the context of a misinterpretation of these coinciding trends.